Last reviewed · How we verify
Ademethionine
At a glance
| Generic name | Ademethionine |
|---|---|
| Also known as | ademethionine for 6 weeks, stage 2, ademethionine for 42 weeks. |
| Sponsor | Zhejiang Hisun Pharmaceutical Co. Ltd. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy
- Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ademethionine CI brief — competitive landscape report
- Ademethionine updates RSS · CI watch RSS
- Zhejiang Hisun Pharmaceutical Co. Ltd. portfolio CI